(Q36573009)

15 August 2017

1 reference

title

Radioimmunotherapy as non-myeloablative conditioning for allogeneic marrow transplantation (English)

1 reference

15 August 2017

3

Brenda M Sandmaier

1 reference

15 August 2017

Wolfgang A Bethge

1

1 reference

15 August 2017

D Scott Wilbur

series ordinal

2

1 reference

15 August 2017

publication date

1 July 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

47

1 reference

15 August 2017

issue

7

1 reference

15 August 2017

page(s)

1205-1214

1 reference

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00423110500485822

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00423110500485822

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00423110500485822

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00423110500485822

Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00423110500485822

Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00423110500485822

188Re-labeled anti-CD66 monoclonal antibody in stem cell transplantation for patients with high-risk acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00423110500485822

Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00423110500485822

Radioimmunotherapy with alpha-particle emitting radioimmunoconjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00423110500485822

Targeted radiotherapy of brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00423110500485822

In vivo evaluation of bismuth-labeled monoclonal antibody comparing DTPA-derived bifunctional chelates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00423110500485822

Bismuth 213-labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmyeloablative allogeneic marrow grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00423110500485822

Radioimmunotherapy with bismuth-213 as conditioning for nonmyeloablative allogeneic hematopoietic cell transplantation in dogs: a dose deescalation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00423110500485822

Demonstration of clonable alloreactive host T cells in a primate model for bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00423110500485822

Selective T-cell ablation with bismuth-213-labeled anti-TCRalphabeta as nonmyeloablative conditioning for allogeneic canine marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00423110500485822

Hepatic sinusoidal obstruction after gemtuzumab ozogamicin (Mylotarg) therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00423110500485822

Antibody therapy for residual disease in acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00423110500485822

Reagents for astatination of biomolecules: comparison of the in vivo distribution and stability of some radioiodinated/astatinated benzamidyl and nido-carboranyl compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00423110500485822

10.1080/00423110500485822

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference